Correction to: British Journal of Cancer (2018) 118, 266–276; doi:https://doi.org/10.1038/bjc.2017.429; published online 04 January 2018
The authors would like to acknowledge the following information for this manuscript: Christos Mikropoulos and Christina G Hutten Selkirk are joint first authors of this manuscript. Brian T Helfand and Rosalind A Eeles contributed equally to this manuscript.
Author information
Consortia
Additional information
The online version of the original article can be found at https://doi.org/10.1038/bjc.2017.429
Rights and permissions
This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
About this article
Cite this article
Mikropoulos, C., Hutten Selkirk, C., Saya, S. et al. Erratum: Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. Br J Cancer 118, e17 (2018). https://doi.org/10.1038/bjc.2018.11
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2018.11
This article is cited by
-
Screening naar prostaatkanker bij mannen met een BRCA2 mutatie: adviezen voor de praktijk gebaseerd op resultaten van internationale studie
Tijdschrift voor Urologie (2020)
-
Bei BRCA-Mutation ist PSA-Wert aussagekräftiger
Uro-News (2018)
-
Bei BRCA-Mutation ist PSA-Wert aussagekräftiger
Im Focus Onkologie (2018)